Biotrin International - Company Logo



 
parvovirus b19 fifth disease
 
  Welcome to Biotrin
 

Biotrin is a healthcare company that specialises in providing a range of novel and proprietary tests for the clinician and research scientist. Biotrin’s headquarters are in Dublin, Ireland where it conducts its research and development, manufacturing and marketing activities.

 
  News
 2 Nov 2012DiaSorin enters molecular Diagnostics with launch of LIAISON Iam analyser
 4 May 2012BIOTRIN INTERNATIONAL LTD SIGNS THE AGREEMENT TO ACQUIRE NORDIAG GROUP’S MOLECULAR DIAGNOSTICS ASSETS
 4 Oct 2011Biotrin Group officially opens new facility in Dublin
 6 May 2011DIASORIN AND PRECISION SYSTEM SCIENCE CO., LTD SIGN AN AGREEMENT TO DEVELOP A MOLECULAR DIAGNOSTIC ANALYZER FOR LAMP ASSAYS.
 18 Jun 2010Biotrin Group Announce Research and Development project for Dublin with the Creation of 40 new jobs
 25 Mar 2010BioMedica Conference, Dublin, Ireland 27th-28th April 2010
 

 

 biomarkers
Infectious Diseases

Biotrin’s lead product range are tests to detect Parvovirus B19, a viral infection that can cause miscarriage in pregnant women. Biotrin is the world leader in Parvovirus B19 testing and the only company to have FDA cleared tests. Other CE marked tests: HHV-6, HHV-8, Respiratory viruses and Hantavirus.
© 2005 Biotrin International
For further information on Fifth Disease click here
Website Design by Net Affinity

Manufacturing / Quality Assurance: 93 The Rise, Mount Merrion, Stillorgan, Co. Dublin, Ireland.
Administration / R&D: Unit 13/14 Holly Avenue, Stillorgan Industrial Park, Blackrock, Co. Dublin, Ireland.
Tel: +353 1 283 1166 | Fax: +353 1 283 1232
Email: info@biotrin.ie
For technical support please email: customercare@biotrin.ie
Company No. 422701